Mylene Mazerolle, R John Kimoff, Sulaiman Khadadah, Pierre Duquette, Vincent Jobin, Yves Lapierre, Andrea Benedetti, Katarina Majetic, Ann Robinson, Elaine Roger, Amit Bar-Or, Marta Kaminska, Gabriel Leonard, Daria A Trojan
BACKGROUND: Obstructive sleep apnea-hypopnea (OSAH) is common in MS patients and is associated with fatigue. We recently published a randomized, controlled trial (RCT) of active vs sham continuous positive airway pressure (CPAP) treatment in MS patients with fatigue, poor sleep quality, and (OSAH) (Mult Scl J 2022;28:82-92). Our aim was to evaluate the long-term effects of CPAP treatment on fatigue (Fatigue Severity Scale, FSS, primary outcome) and other clinical outcomes in MS patients with OSAH...
November 20, 2023: Multiple Sclerosis and related Disorders